#USA #AI #Deloitte #Toronto #Pharmacovigilance

Improve Quality in Pharmacovigilance with AI

As the pharmaceutical landscape evolves, the demand for efficient and precise pharmacovigilance processes has risen dramatically. To tackle this issue, Xtalks will host a pivotal webinar featuring experts from Deloitte. This session focuses on the integration of Artificial Intelligence (AI) in the case intake of adverse events, addressing the growing influx of data and enhancing the quality of assessments.

In the past, pharmacovigilance teams have struggled with managing vast amounts of information from multiple sources, including emails, websites, chatbots, and call centers. Despite advancements in automation, many teams still depend on manual processes to assess and classify each case. This upcoming webinar aims to demonstrate how AI-enabled tools can streamline these critical tasks by improving data intake and quality controls.

Key Discussion Points

The webinar will delve into essential aspects of incorporating AI within regulated environments like pharmacovigilance. Key topics include:

• - Quality Checks: Integrating embedded quality controls within AI systems to ensure data integrity.
• - Confidence Indicators: Utilizing transparent confidence indicators that help teams make informed decisions based on AI analyses.
• - Auditability: Ensuring that all actions taken within the AI systems are traceable and auditable to comply with regulatory standards.
• - Human Oversight: Emphasizing the necessity of maintaining human involvement to oversee AI processes, thereby preserving quality and accountability.

Participants will witness a live demonstration of products such as ElevateSafety™ and Detective, powered by Deloitte's Converge™. These tools showcase how AI can facilitate adverse event detection, data structuring, and routing across diverse data sources, contributing to effective pharmacovigilance operations.

Benefits of AI in Pharmacovigilance

The benefits of implementing AI in pharmacovigilance are substantial. By utilizing these advanced technologies, organizations can:
1. Enhance Data Management: Effectively manage high volumes and varieties of incoming reports and data.
2. Drive Compliance: Ensure adherence to regulatory guidelines while streamlining workflows.
3. Focus Expertise Where Needed: Allow experts to concentrate on more complex cases, boosting overall operational efficiency.

Registration Information

Join Cyle Connell, Associate Vice President of Product Management for ElevateSafety™, and Ellen O'Dea, Senior Manager at Deloitte Consulting LLP, on Wednesday, October 28, 2026, at 1 PM EDT (10 AM PDT). This timely event promises to equip pharmacovigilance teams with practical knowledge on leveraging AI to manage increasing data volumes without compromising quality or compliance.

To secure your spot, visit the registration link: Improve Pharmacovigilance Quality with AI-Enabled Case Intake.

About Xtalks

Xtalks is a vibrant community designed for professionals in pharma, biotech, and healthcare. The platform provides a plethora of resources, including webinars, articles, and expert interviews, fostering informed decision-making in a rapidly changing industry. This event will be instrumental for those seeking to stay at the forefront of pharmacovigilance advancements.

For more information about Xtalks, check out their website: www.xtalks.com or contact them for partnership inquiries regarding webinar hosting.